Haleon (HLN) Shares Outstanding (Diluted Average) (2021 - 2024)
Haleon (HLN) recorded quarterly Shares Outstanding (Diluted Average) of $20.2 billion in Q4 2024, up 43.68% on a QoQ basis from $14.0 billion in Q4 2023, and up 43.68% year-over-year from $14.0 billion in Q1 2024.
Haleon (HLN) Shares Outstanding (Diluted Average) (2021 - 2024) Analysis & Trends
Haleon has disclosed Shares Outstanding (Diluted Average) across 4 years of filings, most recently posting $20.2 billion for Q4 2024.
- Quarterly Shares Outstanding (Diluted Average) rose 43.68% year-over-year to $20.2 billion in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $20.2 billion (up 43.68% YoY) and the FY2024 annual result came in at $20.1 billion, up 42.79% from the prior year.
- Shares Outstanding (Diluted Average) rose to $20.2 billion in Q4 2024, from $14.0 billion in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $20.4 billion in Q4 2021 and troughed at $5.1 billion in Q2 2023.
- A 4-year average of $13.3 billion and a median of $13.8 billion in 2022 frame the typical range for Shares Outstanding (Diluted Average).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) slumped 33.73% — and 2024, when it soared 43.68%.
- Tracing HLN's Shares Outstanding (Diluted Average) over 4 years: stood at $20.4 billion in 2021, then tumbled by 33.73% to $13.5 billion in 2022, then advanced by 3.98% to $14.0 billion in 2023, then jumped by 43.68% to $20.2 billion in 2024.
- Business Quant data shows HLN's Shares Outstanding (Diluted Average) at $20.2 billion in Q4 2024, $14.0 billion in Q4 2023, and $5.1 billion in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Haleon | 1.09 Bn | -773.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 20.15 Bn |
| Dec 31, 2023 | 14.03 Bn |
| May 3, 2023 | 5.14 Bn |
| Dec 31, 2022 | 13.49 Bn |
| Sep 20, 2022 | 6.90 Bn |
| Dec 31, 2021 | 20.35 Bn |